Citalopram in the treatment of alcoholism: A double-blind placebo-controlled study

Pharmacopsychiatry

Volumn 29, Issue 1, 1996, Pages 27-29

  Tiihonen, J ^a   Ryynanen O P ^a   Kauhanen, J ^a   Hakola, H P A ^a   Salaspuro, M ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ABSTINENCE; ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030069067     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979538     Document Type: Article

References (20)

1. Antti-Poika, I., E. Karaharju, R. Roine, M. Salaspuro: Intervention on heavy drinking - a prospective and controlled study of 438 consecutive injured male patients. Alcohol & Alcoholism 23 (1988) 115-121
2. Bruno, F.: Buspirone in the treatment of alcoholic patients. Psychopathology 22: Suppl. 1 (1989) 49-59
3. Hauge, R., O. Irgens-Jensen: Scandinavian drinking survey: sampling operations and data collections. SIFA-stensilserie 44. Oslo, Norway: National Institute for Alcohol Research (SIFA) (1981)
4. Irwin, M., S. Baird, T. L. Smith, M. Schuckit: Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program. Am. J. Psychiatry 145 (1988) 595-599
5. Irwin, M., M. Schuckit, T. L. Smith: Clinical importance of age at onset in type 1 and type 2 primary alcoholics. Arch. Gen. Psychiatry 47 (1990) 320-324
6. Keso, L., M. Salaspuro: Laboratory markers as compared to drinking measures before and after inpatient treatment for alcoholism. Alcoholism: Clin. Exp. Res. 13 (1989) 449-452
7. Keso, L., M. Salaspuro: Comparative value of self-report and blood tests in assessing outcome amongst alcoholics. Brit. J. Addict. 85 (1990a) 209-215
8. Keso, L., M. Salaspuro: Inpatient treatment of employed alcoholics: a randomized clinical trial on Hazelden-type and traditional treatment. Alcoholism: Clin. Exp. Res. 14 (1990b) 584-589
9. Keso, L., M. Salaspuro: Laboratory tests in the follow-up of treated alcoholics: How often should testing be repeated? Alcohol Alcohol. 25 (1990c) 359-363
10. Morgan, M. Y., J. C. Colman, S. Sherlock: The use of a combination of peripheral markers for diagnosing alcoholism and monitoring for continued abuse. Brit. J. Alcohol Alcohol. 16 (1981) 167-177
11. Naranjo, C. A., E. Seller, J. T. Sullivan, D. V. Woodley, K. Kadlec, K. Sykora: The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin. Pharmacol. Therapeutics 4 (1987) 266-274
12. Naranjo, C. A., E. M. Sellers: Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers. Recent Dev. Alcohol. 7 (1989) 255-266
13. O'Malley, S. S., A. J. Jaffe, C. Chang, R. S. Schottenfeld, R. E. Meyer, B. Rounsaville: Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 881-887
14. Regier, D. A., J. H. Boyd, J. D. Burke, D. S. Rae, J. K. Myers, M. Kramer, L. N. Robins, L. K. George, M. Karno, B. Z. Locke: One-month prevalence of mental disorders in the US: Based on the epidemiological catchment area (ECA) sites. Arch. Gen. Psychiatry 45 (1988) 977-986
15. Robins, L. N., J. E. Helzer, M. M. Weissman, H. Orvaschel, E. Gruenberg, J. Burke, D. A. Regier: Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry 41 (1984) 949-958
16. Shaw, S., T. Worner, M. F. Borysow, R. E. Schmitz, C. S. Lieber: Detection of alcoholism relapse: Comparative diagnostic value of MCV, GGT, and AANB. Alcoholism: Clin. Exp. Res. 3 (1979) 297-301
17. Suokas, A.: Brief intervention of heavy drinking in primary health care: Hämeenlinna study. Helsinki, University Printing House (1992)
18. 1A hypothesis of comorbid anxiety and alcoholism. Ann. Clin. Psychiatry 2 (1990) 287
19. Tollefson, G. D., J. Montague-Clouse: The interrelationship of anxiety and alcoholism: a serotonin hypothesis. Family Practice Recertification 11: Suppl. 9 (1989) 79-88
20. Volpicelli, J. R., A. I. Alterman, M. Hayeshida, C. P. O'Brien: Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 876-880